Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 3 Prostatic Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neoplasms 1 Meningioma 1 Ion Beam Radiation Therapy for Tumor Patients 1 Glioma 1 Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1 Astrocytoma 1

Interventions

Doxorubicin 14 pembrolizumab 11 Specimen Handling 11 Magnetic Resonance Spectroscopy 10 Biopsy 9 Cyclophosphamide 8 X-Rays 7 Radiotherapy 7 Nivolumab 7 Ifosfamide 7 Phantoms, Imaging 6 Gemcitabine 6 liposomal doxorubicin 5 Temozolomide 5 Radiation 5 tazemetostat 4 palbociclib 4 Trabectedin 4 Nuclear Medicine Department, Hospital 4 Irinotecan 4 Ipilimumab 4 pazopanib 3 larotrectinib 3 fludarabine 3 cabozantinib 3 atezolizumab 3 Surveys and Questionnaires 3 Radiation Dose Hypofractionation 3 Proton Therapy 3 Carboplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Protons × 90 days × Clear all

NCT04946357 2026-04-06

EXTREM ION

University Hospital Heidelberg

Phase NA Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡